Lunesta Scripts Limited To Five Refills Under Proposed DEA Scheduling

DEA proposes scheduling Sepracor’s sleep aid as a Schedule IV controlled substance limited to five refills in a six-month period. Under the proposed rule, all dispensers and distributors of Lunesta would be required to be registered and to keep on hand inventories of eszopiclone.